Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001554795-20-000313
Filing Date
2020-11-27
Accepted
2020-11-25 19:01:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G osmt1125sch13g.htm SC 13G 33161
  Complete submission text file 0001554795-20-000313.txt   34691
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Subject) CIK: 0001739426 (see all company filings)

EIN.: 000000000
Type: SC 13G | Act: 34 | File No.: 005-90830 | Film No.: 201352411
SIC: 2834 Pharmaceutical Preparations

Mailing Address 65 EAST 55TH STREET 18TH FLOOR NEW YORK NY 10022
Business Address 65 EAST 55TH STREET 18TH FLOOR NEW YORK NY 10022 212-593-6900
Orbit Co-Invest I LLC (Filed by) CIK: 0001751055 (see all company filings)

EIN.: 811293728 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G